Table 2 Characteristics of the study population, according to the occurrence or not of restenosis (n = 54)

Age (years), median [IQR]

59.5 [58.2–60.7]

60 [57.7–63]

Sex, no. (%)

 M

4 (100)

42 (84)

 F

0 (−)

8 (16)

BMI, kg/m², median [IQR]

25.3 [24.8–26.7]

27.2 [25.8–28.1]

Blood pressure (mmHg), median [IQR]

 Systolic

130 [115–137.5]

130 [120–131.2]

 Diastolic

80 [72.5–80]

80 [70–80]

Hypertension, no. (%)

1 (25)

14 (28)

Smoke, no. (%)

4 (100)

39 (78)

Cholesterol (mg/dL), median [IQR]

 Total

157 [147.5–180.7]

174.5 [147.5–192]

 HDL

34.5 [31.7–41]

43 [35–51.2]

 LDL

90.5 [86–116]

109 [70.2–122.5]

Triglycerides (mg/dL), median [IQR]

141.5 [121.5–166.7]

125.5 [103–151.5]

Glycemia (mg/dL), median [IQR]

 Baseline

93.5 [86.2–102.2]

87 [79.7–90]

 2 h

132.5 [117.7–136.7]

106 [93–123]

Glycated hemoglobin (%), median [IQR]

5.6 [5.3–5.8]

5.2 [5–5.5]

Insulin (µU/mL), median [IQR]

9.8 [9.4–10]

3.6 [2.8–4.7]

HOMA IR, median [IQR]

2.23 [2.1–2.4]

0.75 [0.57–0.97]

Creatinine (mg/dL), median [IQR]

1 [1–1.16]

1 [0.8–1.1]

Hemoglobin (mg/dL), median [IQR]

14.2 [13.2–14.5]

14.3 [13.3–15.2]

Adiponectin (µg/mL), median [IQR]

7 [6–8]

11.5 [10–14]

0.206 [0.053–0.796]

Resistin (ng/mL), median [IQR]

13 [5.2–15.5]

6.5 [4–8.2]

TNF-alpha (ng/mL), median [IQR]

18.5 [11–20.7]

8 [7–10]

Time RE-PCI, median [IQR]

8.5 [4–21.2]

29.5 [13.5–34]

Follow-up duration (months), median [IQR]

30 [25.7–32.7]

29.5 [13.5–34]

Death, no. (%)

 Cardiovascular/other causes

0 (−)/−

0 (−)/1 (2)